Nagaokakyo, Japan

Hiroyasu Kadoya

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroyasu Kadoya: Innovator in Glucose Sensing Technologies

Introduction

Hiroyasu Kadoya is a notable inventor from Nagaokakyo, Japan, recognized for his contributions to the field of glucose sensing technologies. With a focus on improving the accuracy and effectiveness of glucose measurement, Kadoya has made significant advancements through his innovative research and development.

Latest Patents

Kadoya holds a patent for a revolutionary reagent for glucose sensors, which includes not only the glucose sensor itself but also a method for manufacturing the device and a glucose measuring apparatus. His patented reagent facilitates the electrochemical, quantitative determination of glucose, utilizing a highly effective combination of flavin adenine dinucleotide glucose dehydrogenase, single-walled carbon nanotubes, and a dispersant to enhance performance.

Career Highlights

Currently, Hiroyasu Kadoya is affiliated with the National Institute of Advanced Industrial Science and Technology (AIST), where he continues to push the boundaries of research in glucose sensing. His innovative findings have positioned him as a leader in the development of advanced glucose measurement solutions.

Collaborations

Kadoya has collaborated with distinguished colleagues, including Hitoshi Muguruma and Atsunori Hiratsuka. Their joint efforts have contributed to the enhancement of glucose sensor technologies and the successful application of Kadoya's patented solutions.

Conclusion

Hiroyasu Kadoya's work exemplifies the spirit of innovation within the field of glucose sensing technologies. With a focus on combining advanced materials and methods, his contributions are paving the way for more efficient and accurate glucose measurement devices, which are essential for diabetics and medical research alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…